ABSTRACT
Introduction Face-to-face group-based diabetes prevention programmes have been shown to be effective in many settings. Digital delivery may suit some patients, but research comparing the effectiveness of digital with face-to-face delivery is scarce. The aim was to assess if digital delivery of the English National Health Service Diabetes Prevention Programme (NHS DPP) is non-inferior to group-based face-to-face delivery in terms of weight change, and evaluate factors associated with differential change. The study included those recruited to the NHS DPP in 2017-2018.
Research design and methods Individual-level data from a face-to-face cohort was compared to two cohorts on a digital pilot who (i) were offered no choice of delivery mode, or (ii) chose digital over face-to-face. Changes in weight at 6 and 12 months were analysed using mixed effects linear regression, having matched participants from the digital pilot to similar participants from face-to-face.
Results Weight change on the digital pilot was non-inferior to face-to-face at both time points: it was similar in the comparison of those with no choice (difference in weight change: −0.284kg [95% CI: −0.712, 0.144] at 6 months) and greater in digital when participants were offered a choice (−1.165kg [95% CI: −1.841, −0.489]). Interactions between delivery mode and sex, ethnicity, age and deprivation were observed.
Conclusions Digital delivery of the NHS DPP achieved weight loss at least as good as face-to-face. Patients who were offered a choice and opted for digital experienced better weight loss, compared to patients offered face-to-face only.
Competing Interest Statement
AM, MH, EB, BM and SC report no conflicts of interest. EM is managing director of a not-for-profit Community Interest Company, HeLP-Digital, which exists to disseminate a digital diabetes self-management programme, HeLP-Diabetes, across the NHS. JV is the national clinical director for diabetes and obesity at NHS England.
Clinical Protocols
https://doi.org/10.17605/OSF.IO/A9PBW
Funding Statement
This work is independent research funded by the National Institute for Health and Care Research (Health Services and Delivery Research, 16/48/07, Evaluating the NHS Diabetes Prevention Programme (NHS DPP): the DIPLOMA research programme (Diabetes Prevention: Long Term Multimethod Assessment)). The views and opinions expressed in this manuscript are those of the authors and do not necessarily reflect those of the National Institute for Health and Care Research or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The North-West Greater Manchester East NHS Research Ethics Committee gave ethical approval for this work (Reference: 17/NW/0426, 01/08/17, amended 29/09/20).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study were used under license from NHS England for the current study only and are not publicly available.
